Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
334.85
0.00 (0.00%)
Nov 1, 2024, 8:30 AM EST - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $10.16 billion as of November 4, 2024. Its market cap has increased by 13.49% in one year.
Market Cap
10.16B
Enterprise Value
9.92B
1-Year Change
13.49%
Ranking
Category
Stock Price
$334.85
Market Cap Chart
Since November 5, 2019, Bio-Rad Laboratories's market cap has decreased from $10.43B to $10.16B, a decrease of -2.59%. That is a compound annual growth rate of -0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 10.38B | 11.64% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 57.32% |
| Dec 31, 2019 | 11.05B | 6.00% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fresenius Medical Care AG | 11.57B |
| AptarGroup | 11.27B |
| Smith & Nephew | 10.92B |
| Catalent | 10.66B |
| Bio-Rad Laboratories | 10.31B |
| Globus Medical | 10.14B |
| Encompass Health | 9.95B |
| Medpace Holdings | 9.91B |